Opaleye Management Inc. Quant / Systematic

CIK: 0001595855 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value ($000): $276,541 (100.0% shares, 0.0% debt)

Holdings (49)

CDXS CODEXIS INC 6.7%
Value ($000) $18,515 Shares 1,350,000 Est. Cost $3.21 Unrealized +389.9%
STXS STEREOTAXIS INC 5.2%
Value ($000) $14,286 Shares 4,070,000 Est. Cost $2.92 Unrealized 0.0%
EPIZYME INC 5.1%
Value ($000) $14,080 Shares 1,365,000 Est. Cost $8.49 Unrealized
HARROW HEALTH 4.8%
Value ($000) $13,319 Shares 2,370,000 Est. Cost $4.19 Unrealized
EIDOS THERAPEUTICS INC 4.0%
Value ($000) $10,991 Shares 305,550 Est. Cost $21.64 Unrealized
TURNING POINT THERAPEUTICS INC 3.9%
Value ($000) $10,810 Shares 287,500 Est. Cost $37.60 Unrealized
AMARIN CORP PLC 3.5%
Value ($000) $9,778 Shares 645,000 Est. Cost $3.50 Unrealized
ODONATE THERAPEUTICS INC 3.3%
Value ($000) $9,111 Shares 350,000 Est. Cost $24.62 Unrealized
OCUL OCULAR THERAPEUTIX INC 3.1%
Value ($000) $8,436 Shares 2,775,000 Est. Cost $3.91 Unrealized +14.4%
AXGN AXOGEN INC 3.0%
Value ($000) $8,376 Shares 700,000 Est. Cost $3.33 Unrealized +395.2%
QURE UNIQURE NV 2.9%
Value ($000) $8,069 Shares 205,000 Est. Cost $44.67 Unrealized +29.1%
CARA THERAPEUTICS INC 2.9%
Value ($000) $8,043 Shares 440,000 Est. Cost $18.28 Unrealized
AUDENTES THERAPEUTICS INC 2.9%
Value ($000) $8,006 Shares 285,000 Est. Cost $26.12 Unrealized
DECIPHERA PHARMACEUTICALS IN 2.8%
Value ($000) $7,806 Shares 230,000 Est. Cost $22.57 Unrealized
BLUEPRINT MEDICINES CORP 2.8%
Value ($000) $7,714 Shares 105,000 Est. Cost $27.77 Unrealized
CYTOKINETICS 2.7%
Value ($000) $7,397 Shares 650,000 Est. Cost $8.27 Unrealized
XOMA XOMA CORP DEL 2.7%
Value ($000) $7,391 Shares 375,000 Est. Cost $8.03 Unrealized +123.4%
ETON ETON PHARMACEUTICALS INC 2.7%
Value ($000) $7,363 Shares 1,165,000 Est. Cost $6.76 Unrealized -5.5%
ACAD ACADIA PHARMACEUTICALS INC 2.6%
Value ($000) $7,198 Shares 200,000 Est. Cost $15.92 Unrealized +90.4%
CERECOR INC 2.6%
Value ($000) $7,190 Shares 2,185,536 Est. Cost $2.99 Unrealized
BIOHAVEN PHARMACEUTICAL HLDG 2.4%
Value ($000) $6,675 Shares 160,000 Est. Cost $43.66 Unrealized
PTCT PTC THERAPEUTICS INC 2.3%
Value ($000) $6,426 Shares 190,000 Est. Cost $28.36 Unrealized +53.5%
TRICIDA INC 2.2%
Value ($000) $6,020 Shares 195,000 Est. Cost $31.08 Unrealized
AVENUE THERAPEUTICS INC 2.1%
Value ($000) $5,677 Shares 952,600 Est. Cost $5.33 Unrealized
FIBROGEN INC 2.0%
Value ($000) $5,547 Shares 150,000 Est. Cost $26.18 Unrealized
SHOCKWAVE MED INC 1.7%
Value ($000) $4,789 Shares 160,000 Est. Cost $29.93 Unrealized
ZYMEWORKS INC 1.5%
Value ($000) $4,216 Shares 170,000 Est. Cost $19.65 Unrealized
QTRX QUANTERIX CORP 1.5%
Value ($000) $4,063 Shares 185,000 Est. Cost $27.89 Unrealized 0.0%
MAGENTA THERAPEUTICS INC 1.4%
Value ($000) $3,950 Shares 385,000 Est. Cost $13.22 Unrealized
TGTX TG THERAPEUTICS INC 1.2%
Value ($000) $3,439 Shares 612,500 Est. Cost $7.37 Unrealized -5.4%
RA PHARMACEUTICALS INC 1.2%
Value ($000) $3,354 Shares 141,800 Est. Cost $25.96 Unrealized
CRNX CRINETICS PHARMACEUTICALS INC 1.1%
Value ($000) $3,113 Shares 207,000 Est. Cost $20.34 Unrealized -4.4%
SYNTHORX INC 1.1%
Value ($000) $2,929 Shares 180,000 Est. Cost $15.38 Unrealized
NEOLEUKIN THERAPEUTICS INC 1.0%
Value ($000) $2,836 Shares 995,000 Est. Cost $2.85 Unrealized
FORTY SEVEN INC 1.0%
Value ($000) $2,729 Shares 425,000 Est. Cost $6.42 Unrealized
NEXTCURE INC 0.9%
Value ($000) $2,622 Shares 85,000 Est. Cost $30.85 Unrealized
FORTRESS BIOTECH INC 0.8%
Value ($000) $2,334 Shares 1,655,000 Est. Cost $1.74 Unrealized
RADIUS HEALTH INC 0.7%
Value ($000) $1,931 Shares 75,000 Est. Cost $25.75 Unrealized
APTOSE BIOSCIENCES INC 0.5%
Value ($000) $1,501 Shares 720,000 Est. Cost $2.08 Unrealized
FLEXION THERAPEUTICS INC 0.5%
Value ($000) $1,439 Shares 105,000 Est. Cost $13.70 Unrealized
CHEMOCENTRYX INC 0.5%
Value ($000) $1,356 Shares 200,000 Est. Cost $6.78 Unrealized
EDAP EDAP TMS SA 0.5%
Value ($000) $1,347 Shares 300,000 Est. Cost $4.49 Unrealized
INTRA CELLULAR THERAPIES INC 0.5%
Value ($000) $1,270 Shares 170,000 Est. Cost $7.47 Unrealized
STRONGBRIDGE BIOPHARMA PLC 0.4%
Value ($000) $1,171 Shares 490,000 Est. Cost $4.28 Unrealized
CYMABAY THERAPEUTICS INC 0.3%
Value ($000) $717 Shares 140,000 Est. Cost $5.12 Unrealized
VERMILLION INC 0.2%
Value ($000) $661 Shares 1,265,000 Est. Cost $0.89 Unrealized
ASSEMBLY BIOSCIENCES INC 0.2%
Value ($000) $492 Shares 50,000 Est. Cost $9.84 Unrealized
BIOLINERX LTD 0.0%
Value ($000) $44 Shares 16,667 Est. Cost $1426.15 Unrealized
PROTEON THERAPEUTICS INC 0.0%
Value ($000) $14 Shares 54,000 Est. Cost $0.26 Unrealized